ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT03950570. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2, Open Label, Dose-Escalation and Expansion Study of Oral ORIN1001 with and Without Chemotherapy in the Treatment of Subjects with Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the anti-tumor effects of ORIN 1001 in patients with advanced solid tumors or relapsed refractory metastatic breast cancer (patients with progressive disease after receiving at least two lines of therapy in the advanced setting).
Study identification
- NCT ID
- NCT03950570
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 58 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 25, 2019 (Actual)
- Primary completion
- Jan 30, 2023 (Actual)
- Completion
- Jan 30, 2023 (Actual)
- Last update posted
- Dec 31, 2024
2019 – 2023
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| University of Arizona Cancer Center | Tucson | Arizona | 85719 | — |
| UCLA Health Burbank Specialty Care | Burbank | California | 91505 | — |
| UCLA Health Laguna Hills Cancer Care | Laguna Hills | California | 92653 | — |
| University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center | Orange | California | 92868 | — |
| University of California Los Angeles (UCLA) - Jonsson Comprehensive Cancer Center (JCCC) - Oncology Center - Westwood | Westwood, Los Angeles | California | 90024 | — |
| University of Colorado Anschutz Medical Campus | Denver | Colorado | 80045 | — |
| Highlands Ranch Hospital | Highlands Ranch | Colorado | 80129 | — |
| University of Colorado Lone Tree Medical Center | Lone Tree | Colorado | 80124 | — |
| University of Miami Hospital and Clinics - Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| St Lukes Cancer Institute | Kansas City | Missouri | 64111 | — |
| Roswell Park Comprehensive Cancer Center (RPCCC) (Roswell Park Cancer Institute (RPCI)) | Buffalo | New York | 14203 | — |
| Northwell Health | New Hyde Park | New York | 11042 | — |
| Northwell Heath Cancer Institute | New Hyde Park | New York | 11042 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Baylor College of Medicine Medical Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03950570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 31, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03950570 live on ClinicalTrials.gov.